학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

A phase II trial of ALK/ROS1 tyrosine kinase inhibitor WX-0593 (iruplinalkib) in ALK-positive and crizotinib-resistant advanced non-small cell lung cancer.

Document Type

Journal

Author

Shi, Yuankai; Chen, Jianhua; Zhang, Helong; Zhang, Zhihong; Zhang, Yiping; Wang, Zhehai; Zhang, Shucai; Zhao, Jian; Liu, Chunling; Wang, Xiuwen; Zhao, Yanqiu; Hu, Changlu; Yang, Lei; Hao, Xuezhi; Wang, Lin; Si, Meimei; Ge, Mingjing; Geng, Huaize

Source

JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2022, 40 16, 1p. Supplement: S

Subject

Language

English

ISSN

15277755

Online Access

Web of Science JCR 저널정보 Find it@PNU

이메일